Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Efficacy in Stereotactic Body Radiation Therapy (SBRT) of Large Hepatocellular Carcinoma (5-10 cm) With or Without Transcatheter Arterial Chemoembolization (TACE)

NCT04512846 is registered in ClinicalTrials.gov with Beijing 302 Hospital as lead sponsor.

NCT NCT04512846
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04512846 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Efficacy in Stereotactic Body Radiation Therapy (SBRT) of Large Hepatocellular Carcinoma (5-10 cm) With or Without Transcatheter Arterial Chemoembolization (TACE)
Lead sponsor
Beijing 302 Hospital
Phase
Observational
Overall status
Recruiting
Start date
August 1, 2020
Completion date
August 30, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

large hcc patients, stereotactic body radiation therapy, transcatheter arterial chemoembolization